Literature DB >> 35149137

Severe cerebral edema in substance-related cardiac arrest patients.

Annelise M Kulpanowski1, William A Copen2, Brandon L Hancock1, Eric S Rosenthal3, David A Schoenfeld4, Jacob A Dodelson1, Brian L Edlow3, W Taylor Kimberly3, Edilberto Amorim5, M Brandon Westover3, Ming Ming Ning3, Pamela W Schaefer2, Rajeev Malhotra6, Joseph T Giacino7, David M Greer8, Ona Wu9.   

Abstract

BACKGROUND: Studies of neurologic outcomes have found conflicting results regarding differences between patients with substance-related cardiac arrests (SRCA) and non-SRCA. We investigate the effects of SRCA on severe cerebral edema development, a neuroimaging intermediate endpoint for neurologic injury.
METHODS: 327 out-of-hospital comatose cardiac arrest patients were retrospectively analyzed. Demographics and baseline clinical characteristics were examined. SRCA categorization was based on admission toxicology screens. Severe cerebral edema classification was based on radiology reports. Poor clinical outcomes were defined as discharge Cerebral Performance Category scores > 3.
RESULTS: SRCA patients (N = 86) were younger (P < 0.001), and more likely to have non-shockable rhythms (P < 0.001), be unwitnessed (P < 0.001), lower Glasgow Coma Scale scores (P < 0.001), absent brainstem reflexes (P < 0.05) and develop severe cerebral edema (P < 0.001) than non-SRCA patients (N = 241). Multivariable analyses found younger age (P < 0.001), female sex (P = 0.008), non-shockable rhythm (P = 0.01) and SRCA (P = 0.05) to be predictors of severe cerebral edema development. Older age (P < 0.001), non-shockable rhythm (P = 0.02), severe cerebral edema (P < 0.001), and absent pupillary light reflexes (P = 0.004) were predictors of poor outcomes. SRCA patients had higher proportion of brain deaths (P < 0.001) compared to non-SRCA patients.
CONCLUSIONS: SRCA results in higher rates of severe cerebral edema development and brain death. The absence of statistically significant differences in discharge outcomes or survival between SRCA and non-SRCA patients may be related to the higher rate of withdrawal of life-sustaining treatment (WLST) in the non-SRCA group. Future neuroprognostic studies may opt to include neuroimaging markers as intermediate measures of neurologic injury which are not influenced by WLST decisions.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brain; Brain edema; Coma; Critical care outcomes; Drug overdose; Humans; Hypoxia-ischemia; Illicit drugs; Neuroimaging; Out-of-hospital cardiac arrest

Mesh:

Year:  2022        PMID: 35149137      PMCID: PMC9282938          DOI: 10.1016/j.resuscitation.2022.01.033

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   6.251


  30 in total

1.  Incidence of adverse cardiovascular events in adults following drug overdose.

Authors:  Alex F Manini; Lewis S Nelson; Barry Stimmel; David Vlahov; Robert S Hoffman
Journal:  Acad Emerg Med       Date:  2012-06-22       Impact factor: 3.451

Review 2.  Neuroimaging in Cardiac Arrest Prognostication.

Authors:  David M Greer; Ona Wu
Journal:  Semin Neurol       Date:  2017-02-01       Impact factor: 3.420

3.  Cerebral Edema After Cardiac Arrest: Tell Tale Sign of Catastrophic Injury or a Treatable Complication?

Authors:  Teddy S Youn; Carolina B Maciel; David M Greer
Journal:  Neurocrit Care       Date:  2016-04       Impact factor: 3.210

4.  Out-of-hospital cardiac arrest surveillance --- Cardiac Arrest Registry to Enhance Survival (CARES), United States, October 1, 2005--December 31, 2010.

Authors:  Bryan McNally; Rachel Robb; Monica Mehta; Kimberly Vellano; Amy L Valderrama; Paula W Yoon; Comilla Sasson; Allison Crouch; Amanda Bray Perez; Robert Merritt; Arthur Kellermann
Journal:  MMWR Surveill Summ       Date:  2011-07-29

5.  Part 1: Executive Summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

Authors:  Raina M Merchant; Alexis A Topjian; Ashish R Panchal; Adam Cheng; Khalid Aziz; Katherine M Berg; Eric J Lavonas; David J Magid
Journal:  Circulation       Date:  2020-10-21       Impact factor: 29.690

6.  Acute brain swelling after out-of-hospital cardiac arrest: pathogenesis and outcome.

Authors:  Y Morimoto; O Kemmotsu; K Kitami; I Matsubara; I Tedo
Journal:  Crit Care Med       Date:  1993-01       Impact factor: 7.598

7.  Recreational drug overdose-related cardiac arrests: break on through to the other side.

Authors:  Jonathan Elmer; Michael J Lynch; Jeffrey Kristan; Patrick Morgan; Stacy J Gerstel; Clifton W Callaway; Jon C Rittenberger
Journal:  Resuscitation       Date:  2015-02-04       Impact factor: 5.262

Review 8.  Adult Advanced Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.

Authors:  Katherine M Berg; Jasmeet Soar; Lars W Andersen; Bernd W Böttiger; Sofia Cacciola; Clifton W Callaway; Keith Couper; Tobias Cronberg; Sonia D'Arrigo; Charles D Deakin; Michael W Donnino; Ian R Drennan; Asger Granfeldt; Cornelia W E Hoedemaekers; Mathias J Holmberg; Cindy H Hsu; Marlijn Kamps; Szymon Musiol; Kevin J Nation; Robert W Neumar; Tonia Nicholson; Brian J O'Neil; Quentin Otto; Edison Ferreira de Paiva; Michael J A Parr; Joshua C Reynolds; Claudio Sandroni; Barnaby R Scholefield; Markus B Skrifvars; Tzong-Luen Wang; Wolfgang A Wetsch; Joyce Yeung; Peter T Morley; Laurie J Morrison; Michelle Welsford; Mary Fran Hazinski; Jerry P Nolan
Journal:  Circulation       Date:  2020-10-21       Impact factor: 29.690

9.  Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017.

Authors:  Lawrence Scholl; Puja Seth; Mbabazi Kariisa; Nana Wilson; Grant Baldwin
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-01-04       Impact factor: 17.586

10.  Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018.

Authors:  Nana Wilson; Mbabazi Kariisa; Puja Seth; Herschel Smith; Nicole L Davis
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-03-20       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.